These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29961236)

  • 1. Early urinary candidate biomarker discovery in a rat thioacetamide-induced liver fibrosis model.
    Zhang F; Ni Y; Yuan Y; Yin W; Gao Y
    Sci China Life Sci; 2018 Nov; 61(11):1369-1381. PubMed ID: 29961236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of paclitaxel on thioacetamide-induced liver fibrosis in a rat model.
    Sharawy MH; El-Awady MS; Makled MN
    J Biochem Mol Toxicol; 2021 May; 35(5):e22745. PubMed ID: 33749060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of
    Wang MH; Chien CY; Yu HM; Wang PY; Lin WJ
    Mol Pharm; 2018 Oct; 15(10):4417-4425. PubMed ID: 30102864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effects of Ophiocordyceps sinensis mycelium on the liver fibrosis induced by thioacetamide.
    Wu YS; Tseng JK; Chou CH; Chiu CH; Lin YL; Chen YC
    Environ Toxicol; 2017 Jun; 32(6):1792-1800. PubMed ID: 28181416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadoxetic acid-enhanced MRI and sonoelastography: non-invasive assessments of chemoprevention of liver fibrosis in thioacetamide-induced rats with Sho-Saiko-To.
    Chen YW; Tsai MY; Pan HB; Tseng HH; Hung YT; Chou CP
    PLoS One; 2014; 9(12):e114756. PubMed ID: 25490034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers.
    Low TY; Leow CK; Salto-Tellez M; Chung MC
    Proteomics; 2004 Dec; 4(12):3960-74. PubMed ID: 15526343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A useful model to audit liver resolution from cirrhosis in rats using functional proteomics.
    Liu EH; Chen MF; Yeh TS; Ho YP; Wu RC; Chen TC; Jan YY; Pan TL
    J Surg Res; 2007 Apr; 138(2):214-23. PubMed ID: 17292413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats.
    Murad HA; Gazzaz ZJ; Ali SS; Ibraheem MS
    Braz J Med Biol Res; 2017 Sep; 50(11):e6665. PubMed ID: 28953991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats.
    Eissa LA; Kenawy HI; El-Karef A; Elsherbiny NM; El-Mihi KA
    Chem Biol Interact; 2018 Oct; 294():91-100. PubMed ID: 30138605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-fibrotic effects of Cuscuta chinensis with in vitro hepatic stellate cells and a thioacetamide-induced experimental rat model.
    Kim JS; Koppula S; Yum MJ; Shin GM; Chae YJ; Hong SM; Lee JD; Song M
    Pharm Biol; 2017 Dec; 55(1):1909-1919. PubMed ID: 28651481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of zedoary turmeric oil on P450 activities in rats with liver cirrhosis induced by thioacetamide.
    Cheng JJ; Yang NB; Wu L; Lin JL; Dai GX; Zhu JY
    Int J Clin Exp Pathol; 2014; 7(11):7854-62. PubMed ID: 25550825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes of key metabolites during liver fibrosis in rats.
    Yu J; He JQ; Chen DY; Pan QL; Yang JF; Cao HC; Li LJ
    World J Gastroenterol; 2019 Feb; 25(8):941-954. PubMed ID: 30833800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aspirin and enoxaparin in a rat model of liver fibrosis.
    Li CJ; Yang ZH; Shi XL; Liu DL
    World J Gastroenterol; 2017 Sep; 23(35):6412-6419. PubMed ID: 29085190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.
    Jang YO; Kim MY; Cho MY; Baik SK; Cho YZ; Kwon SO
    BMC Gastroenterol; 2014 Nov; 14():198. PubMed ID: 25425284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of carnosine against thioacetamide-induced liver cirrhosis in rat.
    Aydin AF; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Güllüoğlu M; Uysal M; Koçak-Toker N
    Peptides; 2010 Jan; 31(1):67-71. PubMed ID: 19958806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats.
    Constantinou MA; Theocharis SE; Mikros E
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):11-9. PubMed ID: 17113614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin administration exacerbates thioacetamide-induced liver fibrosis in mice.
    Dai K; Qi JY; Tian DY
    World J Gastroenterol; 2005 Aug; 11(31):4822-6. PubMed ID: 16097051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effect of flavonoids from Glycyrrhiza uralensis on expressions of TGF-β1 and Caspase-3 in thioacetamide-induced hepatic fibrosis in rats].
    Jing J; Zhao JY; Hua B; Xue MQ; Zhu YF; Liu G; Wang YH; Peng XD
    Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(15):3034-40. PubMed ID: 26677707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal.
    Lukivskaya O; Patsenker E; Lis R; Buko VU
    Eur J Clin Invest; 2008 May; 38(5):317-25. PubMed ID: 18380797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic effects of chronic low-dose exposure of thioacetamide on rats based on NMR metabolic profiling.
    Wei DD; Wang JS; Wang PR; Li MH; Yang MH; Kong LY
    J Pharm Biomed Anal; 2014 Sep; 98():334-8. PubMed ID: 24996005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.